Response to Krieger et al. re: "TSHR/IGF-1R Cross-Talk, Not IGF-1R stimulating antibodies, mediates gravesʼ Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746–747) - Smith, T J; Janssen, J (Thyroid, 2017)